Food and Drug Administration advisers reject MDMA as clinical treatment for PTSD [Video]

Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the banned drugs into the mainstream.

A panel of advisers to the Food and Drug Administration cited flawed study data, questionable research conduct and significant drug risks, including the potential for heart problems, injury and abuse.

However, strong supporters of MDMA therapy continue to praise its effectiveness, including advocate Lori Tipton who took part in the drug’s clinical trials.

Doctors diagnosed the New Orleans resident with post traumatic stress disorder after Hurricane Katrina hit her hometown.

“My brother passed away from an overdose. And then after that, my mother took the lives of two women and then took the life of herself. And I was the person who discovered their bodies within the house,” Tipton said. “I had crazy mood swings, …